ASCO 2004OncoLink attended the 40th Annual Meeting of the American Society of Clinical Oncology, June 5-8, 2004, in New Orleans, LA. Our reporters provided in-depth, up-to-the-minute coverage of sessions and presentations.
ASCO 2004 Plenary Session Highlights for Prostate cancer Patients!
SWOG 99-16: Randomized phase III trial of docetaxel (D)/estramustine (E) versus mitoxantrone (M)/prednisone (P) in men with androgen-independent prostate cancer (AIPCA)
A multicenter phase III comparison of docetaxel + prednisone and mitoxantrone + prednisone in patients with hormone-refractory prostate cancer
...More Plenary Highlights
Exclusive Interview: Gemcitabine and paclitaxel as first line therapy for metastatic breast cancer. Senior Editor, Julia Draznin Maltzman, MD talks with Dr. Paolo Paoletti about this new standard.
Instant Fill in the Blanks Poetry: A creative interactive exercise from our Poet-in-Residence, Alysa Cumings
OncoLink Monthly Poll
Prior to coming to the Oncologist, what research did you do?
We are looking for your input. Please take a moment to fill-out our anonymous eNewsletter survey.